Related Experiment Video

Updated: May 20, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Central diabetes insipidus in newborns: unique challenges in management

Harish Chaudhary1, Bhanu Kiran Bhakhri, Vikram Datta

  • 1Lady Hardinge Medical College & Associated, Hospitals, New Delhi, India.

Pediatric Endocrinology Reviews : PER
|July 13, 2012
PubMed

Insights

Neonatal central diabetes insipidus (CDI) requires careful management due to high fluid needs. Low renal solute load feeds and thiazides may help balance fluids and reduce hyponatremia risk in infants.

Area of Science:

  • Pediatric Endocrinology
  • Neonatology
  • Neuroscience

Background:

  • Central diabetes insipidus (CDI) in neonates can stem from congenital or acquired intracranial insults.
  • Managing CDI in newborns presents unique challenges due to high fluid requirements from milk-based diets.

Observation:

  • This case report details the management of CDI in a male newborn with semilobar holoprosencephaly.
  • The study highlights the difficulties in maintaining water and solute balance in such complex cases.

Findings:

  • Neonates with CDI necessitate high-volume feeds with a low renal solute load (RSL) to mitigate hyponatremia risk associated with anti-diuretic hormone (ADH) therapy.
  • Thiazide diuretics may be beneficial in reducing fluid requirements for these infants.

Implications:

  • Effective management strategies for neonatal CDI are crucial for preventing complications like hyponatremia.
  • Understanding water and solute balance is key when considering various feeding options for affected newborns.

More Related Videos

State of the Art Cranial Ultrasound Imaging in Neonates10:02

State of the Art Cranial Ultrasound Imaging in Neonates

Published on: February 2, 2015

Related Concept Videos

Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...